BLU Overview
Upcoming Projects (BLU)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (BLU)
-
Discussing Bellus BLU-5937 against Merck's gefapixant in Chronic cough, following recent Phase 2b results and FDA meeting
Tickers: BLU, MRK
Executed On: Jul 14, 2022 at 10:00 AM EDT -
A look at the Safety and Efficacy of BLU-5937 in the Treatment of Refractory Chronic Cough
Ticker: BLU
Executed On: Jun 23, 2022 at 03:00 PM EDT
Upcoming & Overdue Catalysts (BLU)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (BLU)
-
BELLUS Health (BLU) Announces Topline Results from its Phase 2b SOOTHE Trial of BLU-5937 for the Treatment of Refractory Chronic Cough
Ticker: BLU
Occurred on: Dec 13, 2021
Strategic Initiatives (BLU)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
